| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:21 UTC |
|---|
| Update Date | 2021-09-14 15:00:47 UTC |
|---|
| HMDB ID | HMDB0013886 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | R-7-Hydroxywarfarin |
|---|
| Description | R-7-Hydroxywarfarin belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position. R-7-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-7-Hydroxywarfarin is an extremely weak basic (essentially neutral) compound (based on its pKa). |
|---|
| Structure | [H][C@@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O InChI=1S/C19H16O5/c1-11(20)9-15(12-5-3-2-4-6-12)17-18(22)14-8-7-13(21)10-16(14)24-19(17)23/h2-8,10,15,21,23H,9H2,1H3/t15-/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C19H16O5 |
|---|
| Average Molecular Weight | 324.3273 |
|---|
| Monoisotopic Molecular Weight | 324.099773622 |
|---|
| IUPAC Name | 2,7-dihydroxy-3-[(1R)-3-oxo-1-phenylbutyl]-4H-chromen-4-one |
|---|
| Traditional Name | 2,7-dihydroxy-3-[(1R)-3-oxo-1-phenylbutyl]chromen-4-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O |
|---|
| InChI Identifier | InChI=1S/C19H16O5/c1-11(20)9-15(12-5-3-2-4-6-12)17-18(22)14-8-7-13(21)10-16(14)24-19(17)23/h2-8,10,15,21,23H,9H2,1H3/t15-/m1/s1 |
|---|
| InChI Key | BQSUFDMOXLLKQK-OAHLLOKOSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Homoisoflavonoids |
|---|
| Sub Class | Homoisoflavones |
|---|
| Direct Parent | Homoisoflavones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Homoisoflavone
- Chromone
- Coumarin
- Benzopyran
- 1-benzopyran
- 1-hydroxy-2-unsubstituted benzenoid
- Pyranone
- Monocyclic benzene moiety
- Pyran
- Benzenoid
- Heteroaromatic compound
- Vinylogous acid
- Ketone
- Oxacycle
- Organoheterocyclic compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.8917 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.88 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 36.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1625.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 241.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 159.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 102.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 495.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 438.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 172.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 867.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 401.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1298.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 296.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 350.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 307.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 251.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 58.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| R-7-Hydroxywarfarin,1TMS,isomer #1 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O)=CC=C2C1=O | 2836.1 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TMS,isomer #2 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O | 2791.3 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TMS,isomer #3 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C | 2931.0 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TMS,isomer #4 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C | 2845.5 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TMS,isomer #1 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O | 2860.6 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TMS,isomer #2 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C | 2910.5 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TMS,isomer #3 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C | 2846.1 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TMS,isomer #4 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 2936.9 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TMS,isomer #5 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 2863.8 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 2965.2 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 3003.7 | Standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 3260.6 | Standard polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 2903.3 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 2832.3 | Standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC(O[Si](C)(C)C)=CC=C2C1=O)O[Si](C)(C)C | 3256.8 | Standard polar | 33892256 | | R-7-Hydroxywarfarin,1TBDMS,isomer #1 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O)=CC=C2C1=O | 3073.0 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TBDMS,isomer #2 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O | 3056.0 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TBDMS,isomer #3 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3203.1 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,1TBDMS,isomer #4 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3124.3 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TBDMS,isomer #1 | CC(=O)C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O | 3288.5 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TBDMS,isomer #2 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3402.1 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TBDMS,isomer #3 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3297.4 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TBDMS,isomer #4 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3451.5 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,2TBDMS,isomer #5 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3358.2 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3603.6 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3575.0 | Standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #1 | CC(=C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3518.1 | Standard polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3496.6 | Semi standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3397.6 | Standard non polar | 33892256 | | R-7-Hydroxywarfarin,3TBDMS,isomer #2 | C=C(C[C@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2C1=O)O[Si](C)(C)C(C)(C)C | 3528.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - R-7-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-7393000000-0afdb9abcd35b089b784 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - R-7-Hydroxywarfarin GC-MS (2 TMS) - 70eV, Positive | splash10-0uxr-7558900000-00410b77c1f9ab3c2c31 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - R-7-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 10V, Positive-QTOF | splash10-056r-0019000000-7b6485c55e9b33d97ed1 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 20V, Positive-QTOF | splash10-0a6r-0279000000-791450fdc9e1965a47c4 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 40V, Positive-QTOF | splash10-000i-1691000000-d0e57dd6926ed43de404 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 10V, Negative-QTOF | splash10-00fr-1169000000-efe13550c4ac1244f21e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 20V, Negative-QTOF | splash10-004i-3696000000-9e96df9b9534ac5208a8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 40V, Negative-QTOF | splash10-07xu-7960000000-e0341f6159f75eb0ab9c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 10V, Negative-QTOF | splash10-00di-0209000000-4ca40447229e091cd2ae | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 20V, Negative-QTOF | splash10-004i-2923000000-3e72a29e03d1a6bf2136 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 40V, Negative-QTOF | splash10-0aou-6920000000-1e1d2a741f4f93113c93 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 10V, Positive-QTOF | splash10-004i-0927000000-c8480424a8742a47267f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 20V, Positive-QTOF | splash10-004i-0921000000-32fa5293827b2726a43a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - R-7-Hydroxywarfarin 40V, Positive-QTOF | splash10-0udi-1930000000-c49b7c630256aba4d109 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|